News
Coachella Valley Behavioral Health Hosts Ceremony to Celebrate Grand Opening
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the opening of its newest acute care hospital, Coachella Valley Behavioral Health, located at 81555 JFK Court in Indio, California. A
Why Medtronic Stock Topped the Market on Thursday
Prominent medical-device maker Medtronic (NYSE: MDT) was a hit on the stock exchange Thursday. The company's share price rose by nearly 2% following regulatory approval of an important new product
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations
Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations
Why Rivian Stock Surged Thursday
Many aggressive growth stocks are rising Thursday as Treasury yields drop and investors anticipate Federal Reserve rate cuts ahead. But shares of electric vehicle maker Rivian Automotive (NASDAQ:
CenterWell Home Health collects 289,000 meals for needy Americans
CenterWell Home Health, one of America’s largest providers of home health, has supplied more than a quarter-million meals in its latest drive to feed people in need in the communities it serves
3 Stocks to Buy Before 2024 That Can Set You Up For Life
You shouldn't have to keep a close eye on your investments. If you find solid stocks to buy, you can leave them in your portfolio and simply wait for their operations to grow and become larger over
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
When dividend stocks crash in value, that sends their yields up in the opposite direction. But there can be danger for investors who load up on a stock just because its yield is high.
Before buying
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
Pfizer (NYSE: PFE) was a top performer when the U.S. government was shoveling COVID-related revenue in its direction. Unfortunately, the past year hasn't been nearly as kind. The former high-flying
EQS-News: Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
Why Vertex Stock Is Soaring Today
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up by more than 11% headed into the latter half of Wednesday's trading session, catapulted higher by the promising results achieved in a mid-stage
Why Pfizer Stock Is Sinking Today
Shares of Pfizer (NYSE: PFE) were sinking 8.3% lower as of 11:25 a.m. ET on Wednesday. The sharp sell-off came after the drugmaker provided its guidance for full-year 2024.
Pfizer expects 2024
1 Biotech Stock That Could Be the Next Amgen
The human genome project, which was completed in 2003, marked a milestone for biotechnology. It opened the door for the creation of hundreds of medicines based on biology, which have improved the
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
2 Big-Name Stocks Are Falling Wednesday -- Here's Why
The stock market looked ready to keep climbing early Wednesday, even as investors were largely in wait-and-see mode during the last day of the Federal Reserve's current monetary policy meeting
If You Had Invested $100 in AT&T in 1995, This Is How Much You Would Have Today
Telecommunications giant AT&T (NYSE: T) is a household name and a well-known dividend stock. Had you invested $100 in AT&T in 1995, your investment would have grown to $476 today. Is that good
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
Outperforming the benchmark S&P 500 index over a long period is a formidable challenge. This task becomes even more daunting when choosing stocks from the healthcare sector, where the competitive
2 Artificial Intelligence Stocks to Buy Hand Over Fist in 2024
For the past few years, Wall Street has witnessed several hot investment trends -- be it cannabis, the metaverse, cryptocurrency, blockchain, cloud computing, and now artificial intelligence (AI)
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
With AbbVie (NYSE: ABBV) reporting on Nov. 30 that it plans to acquire ImmunoGen, (NASDAQ: IMGN) a biotech developing antibody-drug conjugate (ADC) therapies for various cancers, it's clear that the
Humana Earns Top Score in Human Rights Campaign Foundation’s 2023 Corporate Equality Index
Leading US health insurer and health care services company Humana Inc. (NYSE: HUM) has earned a score of 100 percent on the Human Rights Campaign Foundation Corporate Equality Index and the
Is AT&T a Buy?
Telecom giant AT&T (NYSE: T) gets talked about often in the investing world, but it isn't typically positive. Despite having a commanding market share (47% of U.S. wireless subscriptions in the
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
Intellia Therapeutics (NASDAQ: NTLA) and CRISPR Therapeutics (NASDAQ: CRSP) have one big thing in common: They both specialize in the hot area of gene editing, or the repairing of faulty genes
3 Dirt Cheap Stocks That Make Terrific Buys Before the End of the Year
The stock market has climbed this year, but that doesn't mean the bargains are over. Many stocks missed out on the rally even though their long-term outlooks remain solid. And these are the stocks